-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Inhibrx Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2024 to Q1 2025.
- Inhibrx Biosciences, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2025 was -$21K, a 98.1% increase year-over-year.
- Inhibrx Biosciences, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$2.6M, a 43.5% increase from 2023.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)